The high consumption of carotenoids could promote atheroprotective properties, since the overexpression of APOA1 could improve the reverse cholesterol transport, decreasing the cholesterol content in the liver and improving the hallmarks of the steatosis and then the progression of NAFLD [72]. This evidence concerns the gene APOA1 and metabolic dysfunction-associated steatotic liver disease.